Sprouts Farmers Market closes $600 million revolving credit facility
LONDON - GSK Capital B.V. announced Friday it has published its Annual Report and Financial Statements for the year ended December 31, 2024, on the GSK Group website.
The company has submitted copies of the 2024 Annual Report and Financial Statements to the UK Financial Conduct Authority’s National Storage Mechanism submission portal via Electronic Submission System, in compliance with Listing Rule 9.6.1.
The annual report is now available for public viewing through the National Storage Mechanism website.
GSK Capital B.V. is using the exemption available under the Disclosure and Transparency Rules 6.3.5(1A), which allows the company not to set out the full text of the regulated information in its announcement.
V A Whyte, GSK plc Company Secretary, signed the announcement dated June 27, 2025.
The company noted in its press release statement that any forward-looking statements or projections are subject to risks and uncertainties that may cause actual results to differ from projections. These factors are detailed in the "Risk Factors" section of GSK’s Annual Report on Form 20-F for 2024 and Q1 Results for 2025.
GSK Capital B.V. is registered in England and Wales with its UK establishment office located in London.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.